Zevra Therapeutics Quote - ZVRA

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.65

Bid

4.65

Ask

4.67

Volume

82,595

4.55 Day's Range 4.70

3.89 52 Week Range 7.28

Market Cap

195.874M

Previous Close

4.59

Open

4.61

Last Trade

4.65

Last Trade Time

12:21:59

Financial Volume

US$ 382,271

VWAP

4.6283

Average Volume (3m)

198,629

Shares Outstanding

41,853,494

Dividend Yield

PE Ratio

-4.25

Earnings Per Share (EPS)

-1.1

Revenue

27.46M

Net Profit

-46.05M

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kempharm.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was US$4.59. Over the last year, Zevra Therapeutics shares have traded in a share price range of US$ 3.89 to US$ 7.28.

Zevra Therapeutics currently has 41,853,494 shares outstanding. The market capitalization of Zevra Therapeutics is US$195.87 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -4.25.

Zevra Therapeutics Expands Executive Leadership Team

Rahsaan W. Thompson appointed as Chief Legal Officer, Secretary and Compliance Officer Alison Peters appointed as Chief People Officer CELEBRATION, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Zevra...

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders PR Newswire CELEBRATION, Fla. and...

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at SLEEP 2024 Annual Meeting

KP1077 was well tolerated and showed meaningful clinical improvements in patient-reported assessments of daytime sleepiness, sleep inertia, and brain fog Additional data presented on...

Form 4 - Statement of changes in beneficial ownership of securities

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.2	4.49438202247	4.45	4.7	4.29	201907	4.4366737	CS
4	0.12	2.64900662252	4.53	5.2	4.29	183303	4.65149093	CS
12	-0.46	-9.00195694716	5.11	5.3	4.29	198629	4.74826807	CS
26	-0.3	-6.06060606061	4.95	7.28	4.29	245096	5.58726672	CS
52	-0.87	-15.7608695652	5.52	7.28	3.89	203369	5.27323128	CS
156	-1	-17.6991150442	5.65	7.28	3.89	229494	5.27143748	CS
260	-1	-17.6991150442	5.65	7.28	3.89	229494	5.27143748	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DNDelta 9 Cannabis Inc	$ 0.015 (50.00%)	397.77k
THTheratechnologies Inc	$ 2.08 (16.85%)	51.47k
GVCGlacier Media Inc	$ 0.11 (15.79%)	2.82k
NUMINuminus Wellness Inc	$ 0.05 (11.11%)	31.04k
CHRChorus Aviation Inc	$ 2.47 (9.78%)	1.89M
NCFNorthcliff Resources Ltd	$ 0.02 (-20.00%)	39k
AMMAlmaden Minerals Ltd New	$ 0.085 (-19.05%)	1.74k
XLYAuxly Cannabis Group Inc	$ 0.025 (-16.67%)	428.03k
ASNDAscendant Resources Inc	$ 0.035 (-12.50%)	11k
GMTNGold Mountain Mining Corp	$ 0.035 (-12.50%)	18.63k
FCUFission Uranium Corp	$ 1.18 (-0.84%)	4.66M
TTelus Corp	$ 20.77 (-2.03%)	4.52M
VGCXVictoria Gold Corp	$ 1.28 (-5.88%)	3.48M
BITFBitfarms Ltd	$ 3.71 (-2.37%)	2.05M
ACAir Canada	$ 17.34 (4.14%)	1.97M